secwatch.observer — SEC 8-K summary
======================================

Issuer:     ACCENDRA HEALTH INC/VA/ (ACH)
CIK:        0000075252
Form:       8-K
Filed at:   2024-11-04T23:59:59+00:00
Accession:  0001558370-24-014177
Event type: earnings
Sentiment:  neutral
Materiality: 0.65
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Owens & Minor Q3 revenue up 5% to $2.7B; GAAP net loss $0.17/shr; adj EPS $0.42; debt cut $198M
--------------------------------------------------------------------------------

- Consolidated revenue of $2.7B (+5% YoY); GAAP net loss $(13M) or $(0.17)/share.
- Adjusted EBITDA $142M (+5% YoY); adjusted EPS $0.42 vs $0.44 prior year.
- Total debt reduced by $198M in Q3; management expects sequential growth into Q4.
- Patient Direct and Medical Distribution divisions drove top-line growth.
- Adjusted net income $33.2M vs $34.1M YoY, reflecting higher interest costs.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/75252/000155837024014177/0001558370-24-014177-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/75252/000155837024014177/tmb-20241104x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-24-014177

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer